Tohru Hashida
Impact in
- Transplantation top 1%
- Renal Transplantation Outcomes and Treatments
- Chemical Health and Safety top 5%
Papers in
- Co-authors
- Ken‐ichi Inui (19 shared papers)Shinji Üemoto (8 shared papers)Hiroaki Ikesue (37 shared papers)Ikuko Yano (8 shared papers)Kōichi Tanaka (2 shared papers)Hideyuki Saito (2 shared papers)Nobuyuki Muroi (27 shared papers)Yukihiro Inomata (4 shared papers)
- Journals
- Biological and Pharmaceutical Bulletin (8 papers)Frontiers in Pharmacology (4 papers)Clinical Pharmacology & Therapeutics (3 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- JapanUnited StatesSwitzerland
In The Last Decade
Tohru Hashida
81 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 104
- Transplantation 227
- Chemical Health and Safety 16
- Occupational Therapy 94
- Hepatology 107
- Pharmacology 109
Countries citing papers authored by Tohru Hashida
This map shows the geographic impact of Tohru Hashida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tohru Hashida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tohru Hashida more than expected).
Fields of papers citing papers by Tohru Hashida
This network shows the impact of papers produced by Tohru Hashida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tohru Hashida. The network helps show where Tohru Hashida may publish in the future.
Co-authors
The 25 scholars most cited alongside Tohru Hashida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 140 | |
| 2 | 1996 | 129 | |
| 3 | 2001 | 108 | |
| 4 | 2007 | 98 | |
| 5 | 2001 | 88 | |
| 6 | Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations. | 1995 | 87 |
| 7 | 2020 | 60 | |
| 8 | 生物分解ゼラチンヒドロゲルを用いた塩基性線維芽細胞成長因子の持続遊離による重大な肢虚血患者に対する治療血管新生の新しい方法 第I-IIa試験の最初の報告 | 2007 | 52 |
| 9 | 2010 | 38 | |
| 10 | 2021 | 28 | |
| 11 | 2020 | 28 | |
| 12 | 2011 | 24 | |
| 13 | 2020 | 23 | |
| 14 | 2009 | 23 | |
| 15 | 1992 | 19 | |
| 16 | 2021 | 16 | |
| 17 | 2017 | 16 | |
| 18 | 2021 | 14 | |
| 19 | 1995 | 14 | |
| 20 | 2021 | 12 |
About Tohru Hashida
Tohru Hashida is a scholar working on Oncology, Surgery, Occupational Therapy, Pharmacology and Molecular Biology, having authored 91 papers that have together received 1.3k indexed citations. Recurring topics across this work include Safe Handling of Antineoplastic Drugs (12 papers), Pharmacy and Medical Practices (11 papers), Renal Transplantation Outcomes and Treatments (7 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Pharmaceutical Practices and Patient Outcomes (6 papers), Organ Transplantation Techniques and Outcomes (6 papers), Pharmaceutical studies and practices (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). The work is most often cited by research in Transplantation (227 citations), Chemical Health and Safety (16 citations), Occupational Therapy (94 citations), Hepatology (107 citations) and Pharmacology (109 citations). Tohru Hashida has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Ken‐ichi Inui, Shinji Üemoto, Hiroaki Ikesue, Ikuko Yano, Kōichi Tanaka, Hideyuki Saito, Nobuyuki Muroi, Yukihiro Inomata, Satohiro Masuda and Shigetake Sasayama. Their work appears in journals such as Biological and Pharmaceutical Bulletin, Frontiers in Pharmacology, Clinical Pharmacology & Therapeutics, CPT Pharmacometrics & Systems Pharmacology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.